(EYEG) Eyegate Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Eyegate Pharmaceuticals | (EYEG) share price targets
Complete technical analysis of Eyegate Pharmaceuticals (EYEG) by charts plus indicators, forecast predictions and share price targets for Eyegate Pharmaceuticals (EYEG)
Eyegate Pharmaceuticals trades in USA in Health Care sector.
10 day averaged volume of Eyegate Pharmaceuticals is 141
| Date | Daily Closing Price | Open | High | Low | Volume |
| 01 Fri Aug 2025 | 35.67 | 35.55 | 35.67 | 35.55 | 5.674 times |
| 31 Thu Jul 2025 | 35.55 | 35.55 | 35.55 | 35.55 | 0.709 times |
| 30 Wed Jul 2025 | 35.54 | 35.58 | 35.60 | 35.54 | 3.546 times |
| 29 Tue Jul 2025 | 35.62 | 35.62 | 35.62 | 35.62 | 0.709 times |
| 28 Mon Jul 2025 | 35.44 | 35.44 | 35.44 | 35.44 | 0.709 times |
| 25 Fri Jul 2025 | 35.53 | 35.53 | 35.53 | 35.53 | 0.709 times |
| 24 Thu Jul 2025 | 35.43 | 35.43 | 35.43 | 35.43 | 0.709 times |
| 23 Wed Jul 2025 | 35.45 | 35.45 | 35.45 | 35.45 | 0.709 times |
| 22 Tue Jul 2025 | 35.50 | 35.50 | 35.50 | 35.50 | 0.709 times |
| 21 Mon Jul 2025 | 35.42 | 35.42 | 35.42 | 35.42 | 0.709 times |
Stock of Eyegate Pharmaceuticals (EYEG) has showed a significant upmove. This could be a good time to enter in this stock!
Although my analysis for stock is bullish for shortterm, but stock is over bought and there are high chances of some profit booking tomorrow. You might want to sell the stock tomorrow in intra day with a stoploss of 35.7, for a target of 35.5 or 35.39
Share price targets for Eyegate Pharmaceuticals (EYEG)
| Target Type | Value |
| Downside Target | 33.92 |
| Downside Target | 35.47 |
| Downside Target | 35.53 |
| Downside Target | 35.55 |
| Downside Target | 35.62 |
| Downside Target | 35.65 |
| Downside Target | 35.66 |
| Downside Target | 35.67 |
Intraday share price targets for Eyegate Pharmaceuticals (EYEG)
| Target Type | Value |
| Downside Intraday Target | 35.52 |
| Downside Intraday Target | 35.36 |
| Upside Intraday Target | 35.75 |
| Upside Intraday Target | 35.82 |
| Downside Intraday Target | 35.59 |
Weekly technical analysis of Eyegate Pharmaceuticals (EYEG)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 01 Fri Aug 2025 | 35.67 | 35.44 | 35.67 | 35.44 | 3.2 times |
| 25 Fri Jul 2025 | 35.53 | 35.42 | 35.53 | 35.42 | 1.22 times |
| 18 Fri Jul 2025 | 35.29 | 35.23 | 35.29 | 35.11 | 0.82 times |
| 11 Fri Jul 2025 | 35.22 | 35.30 | 35.40 | 35.22 | 1.25 times |
| 03 Thu Jul 2025 | 35.47 | 35.65 | 35.65 | 35.47 | 0.8 times |
Price has moved up this week, and volume has increased substantially. This means that the move can continue in coming weeks.
Monthly technical analysis of Eyegate Pharmaceuticals (EYEG)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 01 Fri Aug 2025 | 35.67 | 35.55 | 35.67 | 35.55 | 0.319 times |
| 31 Thu Jul 2025 | 35.55 | 35.50 | 35.62 | 35.11 | 0.837 times |
| 30 Mon Jun 2025 | 35.65 | 34.91 | 35.65 | 34.88 | 0.5 times |
| 30 Fri May 2025 | 35.11 | 35.02 | 35.11 | 34.59 | 0.157 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Eyegate Pharmaceuticals (EYEG)
Price action analysis of Eyegate Pharmaceuticals ( (EYEG) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Eyegate Pharmaceuticals ( (EYEG) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Eyegate Pharmaceuticals ( (EYEG) ) based on a short to mid term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Eyegate Pharmaceuticals ( (EYEG) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Eyegate Pharmaceuticals stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.
MACD generated a BUY signal for Eyegate Pharmaceuticals in short term and the buy signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Eyegate Pharmaceuticals Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a buy signal for Eyegate Pharmaceuticals in short term and BUY signal is strong.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Eyegate Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 35.57 and Eyegate Pharmaceuticals (EYEG) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Eyegate Pharmaceuticals (EYEG) stock. Volume based technical analysis of Eyegate Pharmaceuticals (EYEG) stock is negative.
Eyegate Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Eyegate Pharmaceuticals ( (EYEG) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Eyegate Pharmaceuticals ( (EYEG) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Eyegate Pharmaceuticals ( (EYEG) ) based on a short to mid term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Eyegate Pharmaceuticals ( (EYEG) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Eyegate Pharmaceuticals stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.
MACD generated a BUY signal for Eyegate Pharmaceuticals in short term and the buy signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Eyegate Pharmaceuticals Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a buy signal for Eyegate Pharmaceuticals in short term and BUY signal is strong.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Eyegate Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 35.57 and Eyegate Pharmaceuticals (EYEG) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Eyegate Pharmaceuticals (EYEG) stock. Volume based technical analysis of Eyegate Pharmaceuticals (EYEG) stock is negative.
Eyegate Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.